{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260806376413/en/Agenus-Reports-Second-Quarter-2026-Results-and-Advances-Phase-3-ROBBIN-Trial-of-BOTBAL-in-Neoadjuvant-MSS-Colon-Cancer", "message": "News view counter 868063 successfully enlarged"}